Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #2236 on Conversion Labs Inc fka CVLB
pmunch
04/08/16 8:42 AM
#2237 RE: stervc #2236
mrgoodtrade
04/08/16 9:14 AM
#2238 RE: stervc #2236
“We believe that this transaction could double our earnings per share from direct-to-consumer sales as compared to our prior economic interest in the Innate Joint Venture,” commented Mark McLaughlin, Chief Executive Officer of Immudyne, Inc.